Samantha Meltzer-Brody, MD

Samantha Meltzer-Brody, MD, director, perinatal psychiatry program, University of North Carolina at Chapel Hill. “FDA approves first treatment for post-partum depression,” FDA News Release.

First-Ever Postpartum Depression Drug Gives Relief Fast
Depression

First-Ever Postpartum Depression Drug Gives Relief Fast

Samantha Meltzer-Brody, MD | April 5, 2019

Brexanolone (Zulresso) is FDA-approved to treat postpartum depression, which puts mother and healthy child development at risk. Learn more.